About Geltor
Geltor is a company based in San Leandro (United States) founded in 2015 by Alexander Lorestani and Nick Ouzounov. Geltor has raised $109.55 million across 4 funding rounds from investors including ADM, RIT Capital Partners and CPT Capital. The company has 38 employees as of December 31, 2022. Geltor operates in a competitive market with competitors including GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
- Headquarter San Leandro, United States
- Employees 38 as on 31 Dec, 2022
- Founders Alexander Lorestani, Nick Ouzounov
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$109.55 M (USD)
in 4 rounds
-
Latest Funding Round
Not available
-
Investors
ADM
& 18 more
-
Employee Count
38
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Geltor
Unlock access to complete
Operations Team
1 people
Co Team
1 people
Finance and Accounting
1 people
Office Team
1 people
Unlock access to complete
Funding Insights of Geltor
Geltor has successfully raised a total of $109.55M across 4 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Geltor
Geltor has secured backing from 19 investors, including venture fund and institutional investors. Prominent investors backing the company include ADM, RIT Capital Partners and CPT Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital fund backed by a single family office
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Venture capital and accelerator services are provided across multiple sectors.
|
Locked | Locked | Locked |
Investor details for Geltor
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Geltor
Investment portfolio details for Geltor
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Geltor
Detailed financials for Geltor
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Geltor Comparisons
Peer comparison for Geltor
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Geltor
Geltor operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of pharmaceuticals and vaccines for various therapeutic areas
|
|
| Locked | Locked | Locked |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| Locked | Locked | Locked |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| Locked | Locked | Locked |
Yeast cells are genetically engineered to produce medicinal products.
|
|
| Locked | Locked | Locked |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| Locked | Locked | Locked |
CRISPR-engineered cell and gene therapies are developed for research applications.
|
Detailed competitors of Geltor
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Geltor
Complete news archive for Geltor
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Geltor
Geltor was founded in 2015.
Geltor is headquartered in San Leandro, United States. It is registered at San Leandro, California, United States.
Alexander Lorestani is the current CEO of Geltor. They have also founded this company.
Geltor is a funded company, having raised a total of $109.55M across 4 funding rounds to date.
As of Dec 31, 2022, the latest employee count at Geltor is 38.
Geltor was founded in 2015 and is headquartered in San Leandro, United States. Operations focus on the biodesign sector, where advanced designer proteins are developed for consumer applications. Protein optimization and fermentation methods are employed to manufacture products such as Collume and Elastapure. These proteins are created without animal-derived materials or genetic modifications.
Geltor's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
Geltor has 19 investors. Key investors include ADM, RIT Capital Partners, CPT Capital, Cultivian Sandbox, and SOSV.